MedTrace Logo

Factors Associated With Maintenance of Antibody Responses to Influenza Vaccine in Older, Community-Dwelling Adults

NCT02401893 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 510

Last updated 2015-03-30

No results posted yet for this study

Summary

Little is known about factors associated with maintenance of hemagglutinin inhibition (HAI) antibodies after influenza vaccination in older adults so the investigators enrolled adults ≥50 years.

Conditions

  • Aging

Interventions

BIOLOGICAL

Influenza Vaccine

Everyone immunized as recommended by current guidelines

Sponsors & Collaborators

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-09-30
Primary Completion
2010-07-31
Completion
2014-01-31

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02401893 on ClinicalTrials.gov